Hemorrhoid-x Treatment Pack Kit
NDC 34666-291

View dosage, usage, ingredients, routes, and UNII mappings.

Product Information

Hemorrhoid-x Treatment Pack is a UNAPPROVED HOMEOPATHIC-approved product labeled by Nartex Laboratorios Homeopaticos Sa De Cv. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white kit for oral; topical administration. This product entry covers the primary NDC 34666-291 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
34666-291
Proprietary Name:
Hemorrhoid-x Treatment Pack
Non-Proprietary Name: [1]
Hemorrhoid-x Treatment Pack
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:

Clinical Specifications

Dosage Form:
Kit - A packaged collection of related material.
Administration Route(s): [4]
  • Oral - Administration to or by way of the mouth.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Labeler & Regulatory Data

Labeler Code:
34666
Marketing Category: [8]
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.

Marketing Timeline

Start Marketing Date: [9]
04-11-2019
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
N

Product Characteristics

Color(s):
WHITE (C48325 - WHITE)
WHITE (C48325)
Shape:
ROUND (C48348)
FREEFORM (C48340)
Size(s):
10 MM
Imprint(s):
NONE

Code Structure Chart

Product Details

What is NDC 34666-291?

The NDC code 34666-291 is assigned by the FDA to the product Hemorrhoid-x Treatment Pack. This pharmaceutical product is labeled by Nartex Laboratorios Homeopaticos Sa De Cv and is currently categorized as listed product. The medication is a kit administered via oral; topical route. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 34666-291-01. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

Adults and childrenover 12 years: take 2 tablets every 6 hoursChildren under 12 years of age: consult a physician Adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Apply generously to affected area up to 2 times daily, especially at night, in the morning or after each bowel movement.reapply if neededChildren under 12 years of age, consult a phsyician.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

  • COLLINSONIA CANADENSIS WHOLE (UNII: IOS9HV04K7)
  • COLLINSONIA CANADENSIS WHOLE (UNII: IOS9HV04K7) (Active Moiety)
  • AESCULUS HIPPOCASTANUM WHOLE (UNII: 2331W47PSX)
  • AESCULUS HIPPOCASTANUM WHOLE (UNII: 2331W47PSX) (Active Moiety)
  • HAMAMELIS VIRGINIANA WHOLE (UNII: V663Q8TEFU)
  • HAMAMELIS VIRGINIANA WHOLE (UNII: V663Q8TEFU) (Active Moiety)
  • KRAMERIA LAPPACEA WHOLE (UNII: 97AC37R8BM)
  • KRAMERIA LAPPACEA WHOLE (UNII: 97AC37R8BM) (Active Moiety)
  • HAMAMELIS VIRGINIANA LEAF (UNII: T07U1161SV)
  • HAMAMELIS VIRGINIANA LEAF (UNII: T07U1161SV) (Active Moiety)

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".